# ENCOMPASS: Expansion Study C

> **NCT04791267** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 61 (actual)

## Conditions studied

- Hypertension
- Diabetes Mellitus, Type 2
- Chronic Kidney Diseases
- Ischemic Heart Disease
- Congestive Heart Failure
- Chronic Obstructive Pulmonary Disease
- Asthma

## Interventions

- **BEHAVIORAL:** Community Health Navigator Program

## Key facts

- **NCT ID:** NCT04791267
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-17
- **Primary completion:** 2023-01-28
- **Final completion:** 2024-01-28
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04791267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04791267, "ENCOMPASS: Expansion Study C". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04791267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*